• search hit 5 of 104225
Back to Result List

836 - Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score [Abstract]

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:M. C. Mir Maresma, M. Marchioni, R. Campi, A. Minervini, M. Kriegmair, Matthias HeckGND, F. Porpiglia, S. Van Bruwaene, E. Linares, V. Hevia, M. Musquera, I. Derweesh, F. Ghali, R. Autorino, A. Veccia, E. Roussel, M. Albertsen, N. Pavan, A. Antonellia, C. Palumbo, U. Capitanio, T. Klatte, S. Erdem, J. Rubio-Briones
URN:urn:nbn:de:bvb:384-opus4-1250477
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/125047
ISSN:2666-1683OPAC
Parent Title (English):European Urology Open Science
Publisher:Elsevier BV
Place of publication:Amsterdam
Type:Article
Language:English
Year of first Publication:2020
Publishing Institution:Universität Augsburg
Release Date:2025/09/10
Volume:19
Issue:Supplement 2
First Page:e1266
Last Page:e1267
Note:
Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details.
DOI:https://doi.org/10.1016/s2666-1683(20)33434-0
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Urologie
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY-NC-ND 4.0: Creative Commons: Namensnennung - Nicht kommerziell - Keine Bearbeitung (mit Print on Demand)